GOLGA2P4

Across TCGA pan-cancer cohorts, GOLGA2P4 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated GOLGA2P4 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GOLGA2P4 RNA is associated with better overall survival. In most high-consensus cancer types, elevated GOLGA2P4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PAAD show a favorable association.

HNSC, ACC, and PAAD are the cancer types where GOLGA2P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	IV	0.773	0.573	.001	42	view →
ACC	DFS	Tertile	All	0.148	0.579	.012	27	view →
PAAD	OS	Tertile	All	0.516	0.302	.005	25	view →
TGCT	OS	Tertile	II,III,IV	0.752	1.000	.019	18	view →
OV	OS	Median	III,IV	0.276	0.360	.016	12	view →
THCA	OS	Quartile	III,IV	0.927	0.982	.010	8	view →
STAD	OS	Tertile	IV	0.708	0.256	.024	6	view →
ESCA	DFS	Median	IV	0.213	0.626	.026	6	view →
UVM	OS	Tertile	All	0.580	0.866	.034	6	view →
LUAD	DFS	Median	IV	0.666	0.978	.015	6	view →
THYM	DFS	Quartile	All	1.000	0.639	.030	4	view →
KIRC	DFS	Tertile	IV	0.203	0.382	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

GOLGA2P4–HNSC (OS)

Open the HNSC breakdown →